{{Rsnum
|rsid=4234218
|Gene=KALRN
|Chromosome=3
|position=124242363
|Orientation=plus
|GMAF=0.3655
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=KALRN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 15.0 | 53.1 | 31.9
| HCB | 21.9 | 50.4 | 27.7
| JPT | 22.1 | 51.3 | 26.5
| YRI | 2.0 | 30.6 | 67.3
| ASW | 1.8 | 40.4 | 57.9
| CHB | 21.9 | 50.4 | 27.7
| CHD | 20.2 | 47.7 | 32.1
| GIH | 20.8 | 41.6 | 37.6
| LWK | 5.5 | 43.6 | 50.9
| MEX | 5.2 | 56.9 | 37.9
| MKK | 10.3 | 45.5 | 44.2
| TSI | 18.6 | 46.1 | 35.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=19706030
|Title=Validation Study of Genetic Associations with Coronary Artery Disease on Chromosome 3q13-21 and Potential Effect Modification by Smoking
|OA=1
}}

{{PMID Auto
|PMID=17357071
|Title=Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}